BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 30156153)

  • 1. Meta-analysis of Clinical Outcomes of Electrical Cardioversion and Catheter Ablation in Patients with Atrial Fibrillation and Chronic Kidney Disease.
    Diemberger I; Genovesi S; Massaro G; Reggiani MLB; Frisoni J; Gorlato G; Mauro E; Padeletti M; Vincenti A; Boriani G
    Curr Pharm Des; 2018; 24(24):2794-2801. PubMed ID: 30156153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal function and outcomes after catheter ablation of patients with atrial fibrillation: The Guangzhou atrial fibrillation ablation registry.
    Deng H; Shantsila A; Xue Y; Bai Y; Guo P; Potpara TS; Zhan X; Fang X; Liao H; Wu S; Lip GYH
    Arch Cardiovasc Dis; 2019; 112(6-7):420-429. PubMed ID: 31133543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of electrical cardioversion on 1-year outcomes in patients with early recurrence after catheter ablation for atrial fibrillation.
    Dong Z; Du X; Hou XX; He L; Dong JZ; Ma CS
    Clin Cardiol; 2021 Aug; 44(8):1128-1138. PubMed ID: 34101841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired renal function is associated with recurrence after cryoballoon catheter ablation for paroxysmal atrial fibrillation: A potential effect of non-pulmonary vein foci.
    Yanagisawa S; Inden Y; Kato H; Fujii A; Mizutani Y; Ito T; Kamikubo Y; Kanzaki Y; Ando M; Hirai M; Shibata R; Murohara T
    J Cardiol; 2017 Jan; 69(1):3-10. PubMed ID: 27499270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors, management, and outcome of cardioversion failure early after atrial fibrillation ablation.
    Ebert M; Stegmann C; Kosiuk J; Dinov B; Richter S; Arya A; Müssigbrodt A; Sommer P; Hindricks G; Bollmann A
    Europace; 2018 Sep; 20(9):1428-1434. PubMed ID: 29165582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic review and meta-analysis of chronic kidney disease as predictor of atrial fibrillation recurrence following catheter ablation.
    Li M; Liu T; Luo D; Li G
    Cardiol J; 2014; 21(1):89-95. PubMed ID: 23990188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improvement in estimated glomerular filtration rate in patients with chronic kidney disease undergoing catheter ablation for atrial fibrillation.
    Navaravong L; Barakat M; Burgon N; Mahnkopf C; Koopmann M; Ranjan R; Kholmovski E; Marrouche N; Akoum N
    J Cardiovasc Electrophysiol; 2015 Jan; 26(1):21-7. PubMed ID: 25142836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes after cardioversion and atrial fibrillation ablation in patients treated with rivaroxaban and warfarin in the ROCKET AF trial.
    Piccini JP; Stevens SR; Lokhnygina Y; Patel MR; Halperin JL; Singer DE; Hankey GJ; Hacke W; Becker RC; Nessel CC; Mahaffey KW; Fox KA; Califf RM; Breithardt G;
    J Am Coll Cardiol; 2013 May; 61(19):1998-2006. PubMed ID: 23500298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concomitant chronic kidney disease increases the recurrence of atrial fibrillation after catheter ablation of atrial fibrillation: a mid-term follow-up.
    Naruse Y; Tada H; Sekiguchi Y; Machino T; Ozawa M; Yamasaki H; Igarashi M; Kuroki K; Itoh Y; Murakoshi N; Yamaguchi I; Aonuma K
    Heart Rhythm; 2011 Mar; 8(3):335-41. PubMed ID: 21056121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of Failed Electrical Cardioversion for Early Recurrence After Catheter Ablation for Atrial Fibrillation as a Predictor of Future Recurrence.
    Nakamaru R; Tanaka N; Okada M; Tanaka K; Ninomiya Y; Hirao Y; Oka T; Inoue H; Koyama Y; Okamura A; Iwakura K; Rakugi H; Sakata Y; Fujii K; Inoue K
    Am J Cardiol; 2019 Mar; 123(5):794-800. PubMed ID: 30558757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Minimal energy requirement for external cardioversion and catheter ablation for long-standing persistent atrial fibrillation.
    Kim IS; Kim TH; Yang PS; Uhm JS; Joung B; Lee MH; Pak HN
    J Cardiol; 2017 Jan; 69(1):162-168. PubMed ID: 26987790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Renal Dysfunction on Left Atrial Structural Remodeling and Recurrence After Catheter Ablation for Atrial Fibrillation - A Propensity Score Matching Analysis.
    Takahashi Y; Yamaguchi T; Fukui A; Otsubo T; Hirota K; Kawano Y; Nakashima K; Tahara M; Kitai T; Kawaguchi A; Takahashi N; Node K
    Circ J; 2020 Jul; 84(8):1254-1260. PubMed ID: 32612018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Pre-Ablation Direct Current Cardioversion for Persistent Atrial Fibrillation to Predict Recurrence of Atrial Fibrillation after Catheter Ablation.
    Kamada H; Mori K; Ueda N; Wakamiya A; Nakajima K; Kamakura T; Wada M; Ishibashi K; Yamagata K; Inoue Y; Miyamoto K; Nagase S; Noda T; Izumi C; Noguchi T; Kusano K; Aiba T
    Int Heart J; 2022; 63(5):828-836. PubMed ID: 36184544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and Clinical Outcomes of Catheter Ablation of Atrial Fibrillation in Patients With Chronic Kidney Disease.
    Ullal AJ; Kaiser DW; Fan J; Schmitt SK; Than CT; Winkelmayer WC; Heidenreich PA; Piccini JP; Perez MV; Wang PJ; Turakhia MP
    J Cardiovasc Electrophysiol; 2017 Jan; 28(1):39-48. PubMed ID: 27782345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maintenance of sinus rhythm after electrical cardioversion for recurrent atrial fibrillation following mitral valve surgery with or without associated radiofrequency ablation.
    van Breugel HN; Gelsomino S; de Vos CB; Accord RE; Tieleman RG; Lucà F; Rostagno C; Renzulli A; Parise O; Lorusso R; Crijns HJ; Maessen JG
    Int J Cardiol; 2014 Aug; 175(2):290-6. PubMed ID: 24882697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advanced interatrial block is an electrocardiographic marker for recurrence of atrial fibrillation after electrical cardioversion.
    Fujimoto Y; Yodogawa K; Maru YJ; Oka E; Hayashi H; Yamamoto T; Iwasaki YK; Hayashi M; Shimizu W
    Int J Cardiol; 2018 Dec; 272():113-117. PubMed ID: 30072150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rate versus rhythm control and outcomes in patients with atrial fibrillation and chronic kidney disease: data from the GUSTO-III Trial.
    Williams ES; Thompson VP; Chiswell KE; Alexander JH; White HD; Ohman EM; Al-Khatib SM
    Cardiol J; 2013; 20(4):439-46. PubMed ID: 23913464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal function and risk of stroke and bleeding in patients undergoing catheter ablation for atrial fibrillation: Comparison between uninterrupted direct oral anticoagulants and warfarin administration.
    Yanagisawa S; Inden Y; Fujii A; Ando M; Funabiki J; Murase Y; Takenaka M; Otake N; Ikai Y; Sakamoto Y; Shibata R; Murohara T
    Heart Rhythm; 2018 Mar; 15(3):348-354. PubMed ID: 29107192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Impact of Elevated Left Atrial Pressure in Sinus Rhythm After Cardioversion on Outcomes After Catheter Ablation for Atrial Fibrillation.
    Kishima H; Mine T; Takahashi S; Ashida K; Ishihara M; Masuyama T
    J Cardiovasc Electrophysiol; 2016 Jul; 27(7):813-9. PubMed ID: 27090869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electrical cardioversion for early recurrences post pulmonary vein isolation.
    von Olshausen G; Paul-Nordin A; Tapanainen J; Jensen-Urstad M; Bastani H; Saluveer O; Bourke T; Drca N; Kennebäck G; Saygi S; Turkmen Y; Insulander P; Braunschweig F
    J Interv Card Electrophysiol; 2023 Apr; 66(3):577-584. PubMed ID: 36085243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.